Certain Investors Seek Injunction against Sale of Beckman Coulter | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Plaintiffs have filed an amendment to their lawsuit against Beckman Coulter seeking to stop the diagnostic firm's board of directors from selling the company to Danaher.

The class action lawsuit is currently pending in the Superior Court of the State of California, County of Orange, and consolidates a number of cases against Beckman Coulter, its board, and certain officers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.